Point Nine uses cookies to monitor the performance of this website and improve user experience.


View Privacy Policy for full details.

Point Nine Left Banner Point Nine Right Banner
Back All News & Events

ESMA updated EMIR Implementation Q&A (November 2021)

2021-11-22 06:11:03

The European Securities and Markets Authority (ESMA), the EU’s securities markets regulator, has updated Q&A on EMIR implementation

ESMA’s latest Q&A Update on EMIR Implementation is focused on two questions:

OTC Question 3 enriched with the additional clarification on ‘Calculation of the clearing threshold’ for financial counterparty that it should it include in the calculation the OTC derivative contracts that are objectively measurable as reducing risks directly relating to the commercial activity or treasury financing activity entered into by the non-financial counterparties that are part of the same group.

OTC Question 10 the European Commission in accordance with article 16b(5) of the ESMA Regulation clarified hedging exemption for non-financial counterparties when using OTC derivative contracts to hedge certain risks.

ESMA will periodically review and update Q & A’s. You can review previous Point Nine comments on ESMA updates here.

    Disclaimer: The content of this website is for general information purposes only. No other use of the content is permitted without the prior written consent of Point Nine. The content of the information found on our website is not comprehensive and does not constitute legal, financial, trading or regulatory advice. Although the information provided through the website is obtained through reliable sources, cannot substitute professional advice nor guarantee the accuracy, validity, timeliness or completeness of any information or data made available to you. Point Nine accepts no responsibility for any loss whatsoever and howsoever arising which might occur from reliance by any person on the content of this website.